诺瓦瓦克斯医药(NVAX.US)周三开盘大涨超17%,报7.32美元,因旗下COVID-19疫苗已获美国食品药品监督管理局批准,但FDA要求提供额外数据。
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.